Literature DB >> 3739000

Dynamics of Anaplasma marginale in splenectomised calves treated with either imidocarb or oxytetracycline.

K L Kuttler.   

Abstract

Neither imidocarb dipropionate (at 5 mg/kg body weight intramuscularly once or twice at a seven-day interval) nor oxytetracycline hydrochloride (at 20 mg/kg body weight intramuscularly once or twice at a seven-day interval) given to animals in the prepatent period of anaplasmosis, prevented the eventual onset of infection. Both compounds delayed the onset of detectable parasitaemia but this action was more noticeable with oxytetracycline. Oxytetracycline given twice significantly reduced the severity of the primary infection but the secondary infection was more severe. Neither compound showed prophylactic properties even though both are effective in extending the prepatent period and, in the case of oxytetracycline, reducing the severity of infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3739000     DOI: 10.1007/bf02359719

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  8 in total

1.  Efficacy of terramycin/LA-200 administered during the prepatent period of anaplasmosis.

Authors:  W P Eckblad; S D Lincoln; R A Magonigle
Journal:  Proc Annu Meet U S Anim Health Assoc       Date:  1979

2.  Cryogenic preservation of Anaplasma marginale with Dimethyl sulfoxide.

Authors:  J N Love
Journal:  Am J Vet Res       Date:  1972-12       Impact factor: 1.156

3.  Chemotherapy to eliminate Anaplasma marginale under field and laboratory conditions.

Authors:  K L Kuttler; L W Johnson; J E Simpson
Journal:  Proc Annu Meet U S Anim Health Assoc       Date:  1980

4.  Absorption, distribution, and excretion of imidocarb dipropionate in sheep.

Authors:  Y O Aliu; R H Davis; B J Camp; K L Kuttler
Journal:  Am J Vet Res       Date:  1977-12       Impact factor: 1.156

5.  Serologic and clinical responses of premunized, vaccinated, and previously infected cattle to challenge exposure by two different Anaplasma marginale isolates.

Authors:  K L Kuttler; J L Zaugg; L W Johnson
Journal:  Am J Vet Res       Date:  1984-11       Impact factor: 1.156

6.  Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.

Authors:  S D Lincoln; W P Eckblad; R A Magonigle
Journal:  Am J Vet Res       Date:  1982-08       Impact factor: 1.156

7.  Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.

Authors:  K L Kuttler
Journal:  Am J Vet Res       Date:  1983-05       Impact factor: 1.156

8.  Pharmacotherapeutics of drugs used in treatment of anaplasmosis and babesiosis.

Authors:  K L Kuttler
Journal:  J Am Vet Med Assoc       Date:  1980-05-15       Impact factor: 1.936

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.